Cargando…
Stem Cell Markers CXCR-4 and CD133 Predict Aggressive Phenotype and Their Double Positivity Indicates Poor Prognosis of Oral Squamous Cell Carcinoma
SIMPLE SUMMARY: Oral cancer is one of the most frequent malignancies in the world, with a poor prognosis. The absence of accurate biomarkers for predicting oral cancer progression is the primary cause of treatment failures. Multiple studies have shown that cancer stem cells play a critical role in t...
Autores principales: | Caspa Gokulan, Ravindran, Devaraj, Halagowder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656999/ https://www.ncbi.nlm.nih.gov/pubmed/34885003 http://dx.doi.org/10.3390/cancers13235895 |
Ejemplares similares
-
HOPX: A Unique Homeodomain Protein in Development and Tumor Suppression
por: Caspa Gokulan, Ravindran, et al.
Publicado: (2022) -
CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012) -
Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells
por: Ranganathan, Santhalakshmi, et al.
Publicado: (2015) -
Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2020) -
Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
por: Hu, Zele, et al.
Publicado: (2020)